Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Marjoram has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Marjoram and cinnamon were given together as a herbal tea in a clinical study, so the two were tested as a unit rather than separately. That means any result belongs to the combination and neither herb's individual contribution can be pulled out of it. Both have separate lines of work on glucose handling, which is the usual stated rationale for pairing them. Read the pairing as tested together, not as two effects added up.
Origanum majorana and Origanum vulgare are close relatives and their essential oils overlap in carvacrol, thymol and terpinene content, with marjoram usually carrying more terpinen-4-ol and less carvacrol. Combining them raises total phenolic monoterpene exposure rather than adding a distinct mechanism. That matters for dosing, since the mucosal irritation from these oils is dose-dependent and cumulative across sources. Count them together, not separately.
Thyme oil is dominated by thymol, marjoram carries a related monoterpene profile, and the two appear together in culinary and antimicrobial preparations. Their contributions to total phenolic monoterpene load stack. The pairing is long-standing kitchen and herbal practice with a clear chemical basis. It is not evidence that the combination does more than either alone.
Rosemary contributes carnosic acid and rosmarinic acid, and marjoram also carries rosmarinic acid as a major phenolic. Both are used as natural antioxidants in food systems, where they slow lipid oxidation. The pairing is standard in seasoning blends and in oil stabilisation. The shared compound means the two overlap rather than complement.
Marjoram and peppermint both appear in carminative herbal teas taken after meals, where the volatile oils are held to relax gut smooth muscle. Peppermint has far more human work behind it than marjoram does. The pairing is traditional and the marjoram side of it rests mainly on custom. Regard the combination as convention with one better-supported half.
Ginger and marjoram show up together in digestive infusions across several herbal traditions. The two have distinct chemistry, gingerols against monoterpenes, so any combined effect would be additive. No controlled work has tested them as a pair. This is practice, not evidence.
Inositol has a substantial human literature in women's hormonal and metabolic support, and marjoram is increasingly added to those blends on the strength of small tea studies. The two work by entirely unrelated routes, inositol as a second messenger precursor and marjoram through its volatile oil and phenolic content. Stacking them is a marketing composition, not a demonstrated interaction. Any benefit in such a product is most likely carried by the inositol.
Marjoram phenolics, chiefly rosmarinic acid, act as chain-breaking antioxidants in lipid systems, the same job tocopherols do. The two are combined in oils and soft gels on the reasoning that phenolics and tocopherols are consumed at different points in the oxidation chain, though whether a mixture outperforms either alone depends entirely on the matrix and has not been shown generally. This is formulation chemistry that protects the product on the shelf. It says nothing about what happens in a person.
Nothing specific on file for Marjoram. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 5 we read for Marjoram. The full linked list is below.
4 sources behind our Marjoram verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 30 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Marjoram is, not how risky it is. A report is not proof Marjoram caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.